# Contact MOTS-c Direct: corrections and editorial inquiries on MOTS-c peptide

> Contact MOTS-c Direct with corrections or editorial inquiries about our MOTS-c peptide research summaries. We are an editorial publisher, not a clinic or vendor.

Editorial inquiries and corrections to our reading of the MOTS-c literature.

## Editorial Inquiries

MOTS-c Direct is an independent editorial digest of the published MOTS-c peptide literature. Use the form below for corrections, source suggestions, or questions about how we have summarized a study. We read the record straight, and we update it when a citation warrants it.

We cannot answer questions about purchasing, dosing, or personal use. We are not a clinic, we do not provide medical advice, and we do not sell, supply, or recommend any product or vendor. For anything clinical, consult an appropriately licensed healthcare professional.

## Send a Message

Complete the fields below — your name, email, and message — and we will route editorial correspondence accordingly. Please include a citation (DOI, PMID, or URL) when you are flagging a factual point so we can check it against the source.

This page does not collect health information and is not a channel for medical questions. Regulatory standing is summarized on [MOTS-c legal status and 503A access](/legal-status); the evidence itself is on [the underlying MOTS-c research](/research).

---

A cobalt-glazed azulejo panel of the MOTS-c record — the mitochondrial peptide's metabolic and exercise-mimetic findings set tile by tile and cited to source, the empty human-trial squares left openly unglazed, and the FDA 503A standing painted before anything else; no clinic behind the panel and nothing here dispensed or sold.
